GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Agile Therapeutics Inc (STU:0AL) » Definitions » 1-Year ROIIC %

Agile Therapeutics (STU:0AL) 1-Year ROIIC % : -393.17% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Agile Therapeutics 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Agile Therapeutics's 1-Year ROIIC % for the quarter that ended in Mar. 2024 was -393.17%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Agile Therapeutics's 1-Year ROIIC % or its related term are showing as below:

STU:0AL's 1-Year ROIIC % is ranked worse than
94.41% of 948 companies
in the Drug Manufacturers industry
Industry Median: 1.07 vs STU:0AL: -393.17

Agile Therapeutics 1-Year ROIIC % Historical Data

The historical data trend for Agile Therapeutics's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agile Therapeutics 1-Year ROIIC % Chart

Agile Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.99 -1,323.18 -133.94 -118.47 -911.90

Agile Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -141.68 -146.40 -4,456.62 -911.90 -393.17

Competitive Comparison of Agile Therapeutics's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Agile Therapeutics's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agile Therapeutics's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Agile Therapeutics's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Agile Therapeutics's 1-Year ROIIC % falls into.



Agile Therapeutics 1-Year ROIIC % Calculation

Agile Therapeutics's 1-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -14.731 (Mar. 2024) - -31.203 (Mar. 2023) )/( 1.756 (Mar. 2024) - 5.735 (Mar. 2023) )
=16.472/-3.979
=-413.97%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Agile Therapeutics  (STU:0AL) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Agile Therapeutics 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Agile Therapeutics's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Agile Therapeutics (STU:0AL) Business Description

Traded in Other Exchanges
Address
500 College Road East, Suite 310, Princeton, NJ, USA, 08540
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.

Agile Therapeutics (STU:0AL) Headlines

No Headlines